Since intestinal inflammation upregulates the ACE2 receptor and the TMPRSS2 protease, IBD patients may be at an increased risk for SARS-CoV-2-infection and might be prone to a more severe disease course. The gene discussed is TMPRSS2; the disease is inflammatory bowel disease.